Improving the standard of care for patients with psoriasis.
David M. Pariser, MD, presented an outline of the proposed American Academy of Dermatology consensus statement (since approved by the AAD Board of Directors), which he summarizes in this article. Pariser then moderated a roundtable discussion, in which participants discussed recent developments in the treatment of psoriasis that led to the new consensus statement. The panelists also addressed how to apply the statement to clinical practice, the effects its changes will have on physicians and patients, how managed care organizations might respond to new therapies, and how physicians can work with MCOs to ensure a smooth transition when integrating these therapies into their practices.
Pariser
David M
DM
Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA.
D002983:Clinical Competence; D003266:Continuity of Patient Care; D006801:Humans; D011565:Psoriasis / Q000175:diagnosis / Q000628:therapy*; D011785:Quality Assurance, Health Care / Q000592:standards*; D012720:Severity of Illness Index